Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crexendo Inc. stock logo
CXDO
Crexendo
$6.57
-0.2%		$7.21
$5.55
▼
$11.23
$217.95M1.12386,148 shs167,075 shs
eGain Corporation stock logo
EGAN
eGain
$7.31
+1.6%		$6.88
$5.81
▼
$15.95
$201.37M0.81215,043 shs70,336 shs
Stem, Inc. stock logo
STEM
Stem
$5.77
-1.1%		$6.67
$4.92
▼
$32.23
$51.67M1.5170,005 shs104,240 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$4.10
+6.5%		$8.05
$3.71
▼
$21.41
$210.86M-0.19260,491 shs178,547 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crexendo Inc. stock logo
CXDO
Crexendo
+0.46%+2.33%-14.10%-31.53%+8.05%
eGain Corporation stock logo
EGAN
eGain
-0.55%-2.97%+9.44%+2.71%+15.78%
Stem, Inc. stock logo
STEM
Stem
-4.98%-1.29%-7.47%-34.40%-59.33%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-0.26%-0.52%-23.76%-55.59%-73.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crexendo Inc. stock logo
CXDO
Crexendo
$6.57
-0.2%		$7.21
$5.55
▼
$11.23
$217.95M1.12386,148 shs167,075 shs
eGain Corporation stock logo
EGAN
eGain
$7.31
+1.6%		$6.88
$5.81
▼
$15.95
$201.37M0.81215,043 shs70,336 shs
Stem, Inc. stock logo
STEM
Stem
$5.77
-1.1%		$6.67
$4.92
▼
$32.23
$51.67M1.5170,005 shs104,240 shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$4.10
+6.5%		$8.05
$3.71
▼
$21.41
$210.86M-0.19260,491 shs178,547 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crexendo Inc. stock logo
CXDO
Crexendo
+0.46%+2.33%-14.10%-31.53%+8.05%
eGain Corporation stock logo
EGAN
eGain
-0.55%-2.97%+9.44%+2.71%+15.78%
Stem, Inc. stock logo
STEM
Stem
-4.98%-1.29%-7.47%-34.40%-59.33%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-0.26%-0.52%-23.76%-55.59%-73.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Crexendo Inc. stock logo
CXDO
Crexendo
2.75
Moderate Buy$10.5060.53% Upside
eGain Corporation stock logo
EGAN
eGain
2.25
Hold$15.25112.07% Upside
Stem, Inc. stock logo
STEM
Stem
1.80
Reduce$7.4529.68% Upside
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest STEM, CXDO, EGAN, and ZSQR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Stem, Inc. stock logo
STEM
Stem
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$6.75
8/14/2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E-)
8/14/2026
Stem, Inc. stock logo
STEM
Stem
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$10.50 ➝ $7.00
8/7/2026
eGain Corporation stock logo
EGAN
eGain
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
8/5/2026
Crexendo Inc. stock logo
CXDO
Crexendo
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $9.00
8/3/2026
Crexendo Inc. stock logo
CXDO
Crexendo
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C+)
7/27/2026
Stem, Inc. stock logo
STEM
Stem
New Street Research logo
New Street Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$8.00
7/27/2026
Stem, Inc. stock logo
STEM
Stem
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$18.00 ➝ $8.00
7/24/2026
Stem, Inc. stock logo
STEM
Stem
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
7/10/2026
Stem, Inc. stock logo
STEM
Stem
Susquehanna logo
Susquehanna
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$10.00 ➝ $7.50
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Crexendo Inc. stock logo
CXDO
Crexendo
$68.17M3.19$0.37 per share17.78$2.08 per share3.14
eGain Corporation stock logo
EGAN
eGain
$88.43M2.23$0.22 per share33.40$2.95 per share2.44
Stem, Inc. stock logo
STEM
Stem
$156.27M0.33N/AN/A($29.34) per share-0.20
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$1.36M148.62N/AN/A$2.63 per share1.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Crexendo Inc. stock logo
CXDO
Crexendo
$5.07M$0.1446.5717.68N/A5.31%14.34%11.44%11/3/2026 (Estimated)
eGain Corporation stock logo
EGAN
eGain
$32.25M$1.385.2123.97N/A41.68%12.56%7.48%9/3/2026 (Estimated)
Stem, Inc. stock logo
STEM
Stem
$137.76M-$8.49N/AN/AN/A-49.37%N/A-21.85%10/28/2026 (Estimated)
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$1.63N/AN/AN/A-773.72%-49.45%-46.88%N/A

Latest STEM, CXDO, EGAN, and ZSQR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/3/2026Q4 2026
eGain Corporation stock logo
EGAN
eGain
$0.04N/AN/AN/A$21.75 millionN/A
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/AN/A
8/12/2026Q2 2026
Stem, Inc. stock logo
STEM
Stem
-$1.75-$1.58+$0.17-$1.58$36.65 million$33.65 million
8/4/2026Q2 2026
Crexendo Inc. stock logo
CXDO
Crexendo
$0.0967$0.12+$0.0233$0.03$24.65 million$24.65 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Crexendo Inc. stock logo
CXDO
Crexendo
N/AN/AN/AN/AN/A
eGain Corporation stock logo
EGAN
eGain
N/AN/AN/AN/AN/A
Stem, Inc. stock logo
STEM
Stem
N/AN/AN/AN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Crexendo Inc. stock logo
CXDO
Crexendo
0.06
2.06
1.98
eGain Corporation stock logo
EGAN
eGain
N/A
2.15
2.15
Stem, Inc. stock logo
STEM
Stem
N/A
0.83
0.77
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A
7.66
7.66

Institutional Ownership

CompanyInstitutional Ownership
Crexendo Inc. stock logo
CXDO
Crexendo
9.53%
eGain Corporation stock logo
EGAN
eGain
53.94%
Stem, Inc. stock logo
STEM
Stem
61.63%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
13.88%

Insider Ownership

CompanyInsider Ownership
Crexendo Inc. stock logo
CXDO
Crexendo
47.20%
eGain Corporation stock logo
EGAN
eGain
38.70%
Stem, Inc. stock logo
STEM
Stem
5.10%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
24.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Crexendo Inc. stock logo
CXDO
Crexendo
12033.25 million17.56 millionOptionable
eGain Corporation stock logo
EGAN
eGain
69027.45 million16.83 millionOptionable
Stem, Inc. stock logo
STEM
Stem
6608.96 million8.50 millionOptionable
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
251.43 million38.96 millionNot Optionable

Recent News About These Companies

Z Squared CEO to Shareholders: "The Scarcest Thing in AI is Not Chips. It is Power.
August 14, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-ceo-to-shareholders-the-scarcest-thing-in-ai-is-not-chips-it-is-power-302851841.html
Coeptis Therapeutics (NASDAQ:ZSQR) Issues Quarterly Earnings Results
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/coeptis-therapeutics-nasdaqzsqr-issues-quarterly-earnings-results-2026-08-13/
Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus
August 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-signs-definitive-agreement-to-acquire-100-of-paradox-data-and-its-union-county-campus-302840797.html
Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:ZSQR) Expands By 120.7%
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/short-interest-in-coeptis-therapeutics-holdings-inc-nasdaqzsqr-expands-by-1207-2026-07-28/
Z Squared Inc. Terminates At-The-Market Sales Agreement and Committed Equity Forward Purchase Agreement
July 17, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-terminates-at-the-market-sales-agreement-and-committed-equity-forward-purchase-agreement-302828055.html
Z Squared Inc. Provides Capital Structure Update
July 15, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-provides-capital-structure-update-302826454.html
Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer
June 30, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-appoints-jeffrey-harris-as-chief-technology-officer-302814078.html
Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy
June 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-raises-approximately-15-3-million-in-non-debt-capital-to-advance-ai-infrastructure-strategy-302813716.html
Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®
June 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/russell-indexes-add-z-squared-inc-to-russell-2000-and-russell-3000-302812718.html
Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power
June 25, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-to-acquire-majority-interest-in-paradox-data-and-its-union-county-campus-a-next-generation-data-center-development-targeting-up-to-150-mw-of-firm-power-302810183.html
Z Squared to Participate in Maxim Group's AI Data Center Summit
June 9, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-to-participate-in-maxim-groups-ai-data-center-summit-302794415.html
Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout
June 4, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-enters-50-million-committed-equity-forward-purchase-agreement-to-support-ai-infrastructure-buildout-302791528.html
Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes
May 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-announces-preliminary-inclusion-in-russell-3000-and-russell-2000-indexes-302782976.html
Vanderbilt Report: Z Squared Locks In Zero-Cash, Zero-Debt Path to 42 MW of AI-Ready Power
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301053/0/en/vanderbilt-report-z-squared-locks-in-zero-cash-zero-debt-path-to-42-mw-of-ai-ready-power.html
Z Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference Workloads
May 19, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-outlines-phase-1-plan-to-reach-100-mw-of-ai-ready-infrastructure-for-inference-workloads-302775928.html
Z Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory Board
May 4, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-appoints-jon-najarian-pete-najarian-marc-lopresti-and-jay-zapata-to-newly-formed-advisory-board-302761728.html
Z Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MW
April 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-to-acquire-skycore-digital-adding-24-mw-of-energized-ai-infrastructure-with-expansion-path-to-42-mw-302756527.html
Z Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global Market
April 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/z-squared-inc-to-ring-the-nasdaq-closing-bell-in-celebration-of-its-listing-on-the-nasdaq-global-market-302756362.html
Coeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing Application
April 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-04/68143246-coeptis-therapeutics-announces-approval-of-z-squared-inc-s-nasdaq-listing-application-399.htm
Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution
April 27, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/04/27/10371853.htm
Coeptis Therapeutics Receives Shareholder Approval Towards Z Squared Merger
April 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-02/67632267-coeptis-therapeutics-receives-shareholder-approval-towards-z-squared-merger-399.htm

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
First Internet Bancorp logo illuminated on a glass panel beside a bank card and smartphone with financial charts.
System Upgrade: First Internet Bancorp Options Surge
By Jeffrey Neal Johnson | August 4, 2026
AirJoule logo over flowing water stream, symbolizing water-from-air technology and clean water production innovation.
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
By Thomas Hughes | July 27, 2026
Illustration of a chip-like structure displaying AMD and Anthropic logos connected by colorful data streams in a server room.
AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
By Jeffrey Neal Johnson | July 23, 2026
AMD and Cerebras logos connected by glowing cables between server hardware racks in a data center.
AMD and Cerebras Create A New Blueprint For Hardware
By Jeffrey Neal Johnson | July 24, 2026
Glass office towers with glowing digital network lines overlay, symbolizing tech industry data connectivity and market activity.
Buy the Dip or Run: 3 Software Stocks Down 50% Face Their Moment of Truth
By Bridget Bennett | August 7, 2026
Crexendo stock logo

Crexendo NASDAQ:CXDO

$6.56 -0.02 (-0.23%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Crexendo, Inc. provides cloud communication platform and services, video collaboration, and managed IT services for businesses in the United States and internationally. It operates through two segments, Cloud Telecommunications Services and Software Solutions. The Cloud Telecommunications segment provides telecommunications services that transmit calls using Internet protocol (IP) or cloud technology, which converts voice signals into digital data packets for transmission over the Internet or cloud; and broadband Internet services, as well as develops end user portals for account and license management, and billing and customer support. This segment is also involved in the sale and lease of cloud telecommunications equipment. In addition, it offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over high-speed internet connection through various devices and user interfaces, such as desktop phones and/or mobile, and desktop applications under the Crexendo brand name. The Software Solutions segment provides a suite of unified communications, collaboration, video conferencing, and contact center solutions. This segment also offers SNAPsolution, an IP-based platform; SNAPaccel, a software-as-a-service based software; subscription maintenance and support services; and professional services, including consulting, technical support, resident engineer, design, and installation services. The company was formerly known as iMergent, Inc. and changed its name to Crexendo, Inc. in May 2011. Crexendo, Inc. was incorporated in 1995 and is based in Tempe, Arizona.

eGain stock logo

eGain NASDAQ:EGAN

$7.31 +0.12 (+1.61%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

eGain Corporation develops, licenses, implements, and supports customer service infrastructure software solutions in North America, Europe, the Middle East, Africa, and the Asia Pacific. It provides eGain Knowledge Hub, which helps businesses to centralize knowledge, policies, procedures, situational expertise, best-practices, while delivering guided, and personalized solutions to customers and agents; eGain Conversation Hub for digital-first, omnichannel interaction management within a modern, purpose-built desktop; and eGain Analytics Hub enables clients to measure, manage, and optimize omnichannel service operations and knowledge. The company also offers subscription services that provides customers with access to its software on a cloud-based platform; and professional services, such as consulting and implementation, training, and managed services. It serves customers in various industry sectors, including the financial services, telecommunications, retail, government, healthcare, and utilities. The company was incorporated in 1997 and is headquartered in Sunnyvale, California.

Stem stock logo

Stem NYSE:STEM

$5.77 -0.07 (-1.13%)
As of 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Stem, Inc. operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems. It serves commercial and industrial enterprises, independent power producers, renewable project developers, and utilities and grid operators. The company was incorporated in 2009 and is headquartered in San Francisco, California.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$4.10 +0.25 (+6.49%)
As of 03:38 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas